Chile

Reimbursed Care Access

Chile maintains a controlled-substances regulatory framework (Ley N°20.000) that generally classifies classical psychedelic compounds (psilocybin, MDMA, DMT, mescaline, 2C-series, 5‑MeO‑DMT, ibogaine) as controlled, with no routine public reimbursement outside authorized research. Ketamine is a registered anesthetic and is widely used clinically (including growing private-sector off‑label psychiatric programs); esketamine (Spravato) has a commercial registration and is available under medical supervision but access and public reimbursement are limited and largely handled in private settings.